SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investor community sentiment pivots toward a potential turnaround, fueled by a buyout rumor involving Nelson Peltz and aggressive short-covering activity. While some traders are expressing frustration over dividend cuts and disappointing sales data, others are pointing to a low float and high short interest as signs of an imminent squeeze.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following a strong quarterly earnings report that featured a massive revenue backlog and raised full-year guidance, effectively silencing concerns about waning AI demand. While some community members remain skeptical of the firm's heavy debt load and cash burn, bulls are actively focused on the significant contract wins and institutional support as catalysts for a potential short squeeze.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after a massive earnings beat and robust forward guidance that suggests the AI infrastructure demand remains strong, triggering active discussions among investors about potential short squeeze scenarios. The community is focused on the company's record backlog and improved profitability as key indicators that the stock is currently undervalued relative to its peers.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging as investors react to a powerful earnings beat, highlighted by triple-digit revenue growth and a significant swing to positive EBITDA. The community is actively cheering a potential short squeeze, with many retail traders celebrating the stock's performance as a direct rebuke to high-profile skeptics who had taken large short positions.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is facing intense scrutiny as investors express frustration over a lack of tangible AI infrastructure deals and consistent insider selling, overshadowing their ongoing transition into a data center operator. The community remains deeply divided, with many citing poor management execution and recent earnings misses as primary drivers for the stock's significant volatility and downward pressure.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending after announcing positive Phase 3 results for its DT120 ODT treatment in Generalized Anxiety Disorder, confirming rapid efficacy across multiple clinical trials. The community is actively debating the company's valuation, the potential for a strategic buyout, and how this performance compares to other players like Compass Pathways in the evolving psychedelic psychiatry sector.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors brace for the upcoming Phase 2 top-line data readout for ABCL635, a pivotal event that could validate the company's proprietary drug discovery platform. Community sentiment is deeply divided between long-term holders betting on a major re-rating upon successful clinical results and active traders scrutinizing the stock's high short interest and volatility ahead of the imminent trial disclosure.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is experiencing significant volatility as investors weigh strong travel demand and recent record revenue against concerns over rising fuel costs and geopolitical tensions in the Middle East. While some market participants are focused on share buybacks and fleet modernization as long-term catalysts, the community remains divided, with active debates over the stock's sensitivity to energy prices and the potential impact of labor agreements.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum is generating significant investor attention following its recent IPO and a series of strategic collaborations with major technology firms, fueling debates about its long-term valuation compared to organic growth within the quantum sector. Community members are actively dissecting the stock's market debut, comparing its performance to other quantum-focused competitors, and monitoring its integration into broader industrial AI and cloud computing ecosystems.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is currently the subject of intense community debate, with investors weighing the potential of its wet AMD treatment AXPAXLI against concerns over management's ability to successfully navigate the NDA submission process. While supporters point to strong clinical data and a significant market opportunity as catalysts for a potential buyout, skeptics are actively highlighting the company's cash burn and recent share volatility as evidence of underlying weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


skydentalimplants

Sky Dental Implant Center